Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lederman

Showing results (241-250 of 303) with videos related to

Pageof 31
Sort By:
Open Forum Infectious Diseases|June 23, 2021
Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV InfectionSamuel R Schnittman, Helen Byakwaga, Yap Boum, et al.
Journal of Clinical Pharmacology|June 25, 2021
Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 StudySelwyn J Hurwitz, Sijia Tao, Christina Gavegnano, et al.
Science (New York, N.Y.)|July 26, 2008
Whither or wither microbicides?Robert M Grant, Dean Hamer, Thomas Hope, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2025
Inflammation, antiretroviral therapy continuation, and HIV disease progression in postpartum women with HIVRupak Shivakoti, Mark J Giganti, Michael M Lederman, et al.
Open Forum Infectious Diseases|January 5, 2026
Monocyte Activation in People With HIV and Tuberculosis Coinfection and Effect of Tuberculosis Preventive Therapy: An Analysis of the ACTG A5279/BRIEF TB TrialMoises A Huaman, Manuel G Feria, Michelle A Kendall, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infectionCraig W Hendrix, Ann C Collier, Michael M Lederman, et al.
Iscience|October 27, 2025
Dysbiosis modulates CD8<sup>+</sup> tissue-resident memory cells through a mechanism requiring polyamine metabolism during HIV infectionSangeetha Jayaraman, Shanmuga Mahalingam, Michael M Lederman, et al.
The Journal of Infectious Diseases|June 16, 2011
Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic successRajeev K Mehlotra, Vinay K Cheruvu, Melinda J Blood Zikursh, et al.
The Journal of Infectious Diseases|March 4, 2014
Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV diseaseCarey L Shive, Joseph C Mudd, Nicholas T Funderburg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 17, 2024
Brief Report: Low-Dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals With Chronically Treated HIV-1 InfectionJoshua C Cyktor, Eunice Yeh, Heather Ribaudo, et al.
Pageof 31

Showing results (241-250 of 303) with videos related to

Sort By:
Pageof 31
Open Forum Infectious Diseases|June 23, 2021
Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV InfectionSamuel R Schnittman, Helen Byakwaga, Yap Boum, et al.
Journal of Clinical Pharmacology|June 25, 2021
Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 StudySelwyn J Hurwitz, Sijia Tao, Christina Gavegnano, et al.
Science (New York, N.Y.)|July 26, 2008
Whither or wither microbicides?Robert M Grant, Dean Hamer, Thomas Hope, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2025
Inflammation, antiretroviral therapy continuation, and HIV disease progression in postpartum women with HIVRupak Shivakoti, Mark J Giganti, Michael M Lederman, et al.
Open Forum Infectious Diseases|January 5, 2026
Monocyte Activation in People With HIV and Tuberculosis Coinfection and Effect of Tuberculosis Preventive Therapy: An Analysis of the ACTG A5279/BRIEF TB TrialMoises A Huaman, Manuel G Feria, Michelle A Kendall, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infectionCraig W Hendrix, Ann C Collier, Michael M Lederman, et al.
Iscience|October 27, 2025
Dysbiosis modulates CD8<sup>+</sup> tissue-resident memory cells through a mechanism requiring polyamine metabolism during HIV infectionSangeetha Jayaraman, Shanmuga Mahalingam, Michael M Lederman, et al.
The Journal of Infectious Diseases|June 16, 2011
Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic successRajeev K Mehlotra, Vinay K Cheruvu, Melinda J Blood Zikursh, et al.
The Journal of Infectious Diseases|March 4, 2014
Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV diseaseCarey L Shive, Joseph C Mudd, Nicholas T Funderburg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 17, 2024
Brief Report: Low-Dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals With Chronically Treated HIV-1 InfectionJoshua C Cyktor, Eunice Yeh, Heather Ribaudo, et al.
Pageof 31